The "Global Gastro-Esophageal Reflux Disease Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
Global Gastro-Esophageal Reflux Disease Market and Competitive Landscape - 2020, provides comprehensive insights into the Gastro-Esophageal Reflux Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Gastro-Esophageal Reflux Disease market size and drug sales. It also provides insights into Gastro-Esophageal Reflux Disease epidemiology and late stage pipeline.
Research Scope:
- Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
- Gastro-Esophageal Reflux Disease pipeline: Find out drugs in clinical trials for the treatment of Gastro-Esophageal Reflux Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
- Gastro-Esophageal Reflux Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Gastro-Esophageal Reflux Disease by countries
- Gastro-Esophageal Reflux Disease drugs: Identify key drugs marketed and prescribed for Gastro-Esophageal Reflux Disease in the US, including trade name, molecule name, and company
- Gastro-Esophageal Reflux Disease drugs sales: Find out the sales value for Gastro-Esophageal Reflux Disease drugs by countries
- Gastro-Esophageal Reflux Disease market valuations: Find out the market size for Gastro-Esophageal Reflux Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
- Gastro-Esophageal Reflux Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
- Evaluate commercial market opportunities for Gastro-Esophageal Reflux Disease drugs
- Synthesize insights for business development & licensing
- Track market size, competitor drug sales, market shares in the Gastro-Esophageal Reflux Disease market
- Develop in-depth knowledge of competition and markets
- Analyze Gastro-Esophageal Reflux Disease drug sales data to update your brand planning trackers
- Develop tactics and strategies to take advantage of opportunities in the market
- Track Market Events and Trends and analyze key events in the Gastro-Esophageal Reflux Disease market
- Develop forecast models, healthcare frameworks, or economic models
- Answer key business questions; supports decision making in R&D to long term marketing strategies
Key Topics Covered:
1. Gastro-Esophageal Reflux Disease Treatment Options
2. Gastro-Esophageal Reflux Disease Pipeline Insights
2.1. Gastro-Esophageal Reflux Disease Phase 3 Clinical Trials
2.2. Gastro-Esophageal Reflux Disease Phase 2 Clinical Trials
2.3. Gastro-Esophageal Reflux Disease Phase 1 Clinical Trials
3. Gastro-Esophageal Reflux Disease Epidemiology Analysis by Countries
4. US Gastro-Esophageal Reflux Disease Market Insights
4.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in US
4.2. US Gastro-Esophageal Reflux Disease Market Size & Forecast
4.3. US Gastro-Esophageal Reflux Disease Drugs Sales & Forecast
4.4. US Gastro-Esophageal Reflux Disease Market Share Analysis
5. Germany Gastro-Esophageal Reflux Disease Market Insights
5.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in Germany
5.2. Germany Gastro-Esophageal Reflux Disease Market Size & Forecast
5.3. Germany Gastro-Esophageal Reflux Disease Drugs Sales Forecast
5.4. Germany Gastro-Esophageal Reflux Disease Market Share Analysis
6. France Gastro-Esophageal Reflux Disease Market Insights
6.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in France
6.2. France Gastro-Esophageal Reflux Disease Market Size & Forecast
6.3. France Gastro-Esophageal Reflux Disease Product Sales Forecast
6.4. France Gastro-Esophageal Reflux Disease Market Share Analysis
7. Italy Gastro-Esophageal Reflux Disease Market Insights
7.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in Italy
7.2. Italy Gastro-Esophageal Reflux Disease Market Size & Forecast
7.3. Italy Gastro-Esophageal Reflux Disease Product Sales Forecast
7.4. Italy Gastro-Esophageal Reflux Disease Market Share Analysis
8. Spain Gastro-Esophageal Reflux Disease Market Insights
8.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in Spain
8.2. Spain Gastro-Esophageal Reflux Disease Market Size & Forecast
8.3. Spain Gastro-Esophageal Reflux Disease Product Sales Forecast
8.4. Spain Gastro-Esophageal Reflux Disease Market Share Analysis
9. UK Gastro-Esophageal Reflux Disease Market Insights
9.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in UK
9.2. UK Gastro-Esophageal Reflux Disease Market Size & Forecast
9.3. UK Gastro-Esophageal Reflux Disease Product Sales Forecast
9.4. UK Gastro-Esophageal Reflux Disease Market Share Analysis
10. Europe Gastro-Esophageal Reflux Disease Market Insights
10.1. Europe Gastro-Esophageal Reflux Disease Market Size & Forecast
10.2. Europe Gastro-Esophageal Reflux Disease Product Sales Forecast
10.3. Europe Gastro-Esophageal Reflux Disease Market Share Analysis
11. Japan Gastro-Esophageal Reflux Disease Market Insights
11.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in Japan
11.2. Japan Gastro-Esophageal Reflux Disease Market Size & Forecast
11.3. Japan Gastro-Esophageal Reflux Disease Product Sales Forecast
11.4. Japan Gastro-Esophageal Reflux Disease Market Share Analysis
12. Global Gastro-Esophageal Reflux Disease Market Insights
12.1. Global Gastro-Esophageal Reflux Disease Market Size & Forecast
12.2. Global Gastro-Esophageal Reflux Disease Product Sales Forecast
12.3. Global Gastro-Esophageal Reflux Disease Market Share Analysis
For more information about this report visit https://www.researchandmarkets.com/r/6yq1q5
View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005682/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900